TCT: Ticagrelor Monotherapy Within One Month of DAPT Noninferior to Continued DAPT

FRIDAY, Oct. 27, 2023-- For patients with acute coronary syndrome (ACS), stopping dual antiplatelet therapy (DAPT) within one month for ticagrelor monotherapy is noninferior and superior to 12 months of ticagrelor-based DAPT, according to a study...